2024-12-13 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report

This report analyzes Intuitive Surgical Inc. (ISRG), a company that develops and manufactures robotic surgical systems, based on the provided data.

**1. Performance Comparison & Divergence:**

Intuitive Surgical's cumulative return (298.898%) significantly outperforms the S&P 500 (VOO) cumulative return (122.067%). The difference is 176.8%, placing it at the 94th percentile of its historical range relative to the S&P 500. This indicates strong historical outperformance.  The provided alpha consistently shows near zero, suggesting that the outperformance isn't necessarily due to unique management skill but rather the inherent risk and potential reward associated with the company's business.  The consistently high Beta reflects the stock's sensitivity to market movements.

**2. Recent Price Movement:**

* **Closing Price:** $543.60 (Last market: $548.03)
* **5-Day Moving Average:** $543.72
* **20-Day Moving Average:** $541.26
* **60-Day Moving Average:** $512.91

The price is slightly below the 5-day and 20-day moving averages, suggesting a minor short-term downtrend.  However, it's significantly above the 60-day moving average, indicating a longer-term uptrend.  The difference between the last market price ($548.03) and the closing price suggests a minor dip, not a significant drop.

**3. Technical Indicators & Expected Return:**

* **RSI (Relative Strength Index):** 51.29 -  Near neutral; neither overbought nor oversold.
* **PPO (Price Oscillator):** -0.33 - Suggests a slightly bearish momentum.
* **20-Day Relative Divergence:** -2.3 - Indicates a recent short-term price decline.
* **Expected Return (2+ years):** 106.8% - This represents the projected excess return over the S&P 500 with a long-term (2+ years) investment strategy.  This is a significant figure, highlighting the potential for high returns, but it's crucial to remember that this is a projection and actual returns may differ.

**4. Recent Earnings Analysis:**

The provided earnings data shows some fluctuation in EPS and revenue:

* **EPS:** While EPS showed growth in Q3 2024 compared to Q2 and Q1 2024, there was a slight decrease compared to Q4 2023.  The provided data contains a duplicate entry for October 18th, 2024.
* **Revenue:** Revenue demonstrates a generally increasing trend but with some minor quarter-to-quarter variation.
* **Notable Beats/Misses:**  Without expectations data, it is impossible to comment on whether these results constitute a beat or miss versus expectations.


**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue is consistently high, although there's some fluctuation quarter-to-quarter. Profit margins are strong and generally consistent, hovering around 66-68%.
* **Capital and Profitability:** Equity is increasing, indicating growth in the company's net worth. ROE (Return on Equity) fluctuates slightly, showing periods of higher and lower profitability.

**6. News and Recent Issues:**

This section requires current news and analyst information not provided in the initial data.  Without access to real-time news and analyst opinions, a comprehensive analysis of recent market outlook and analyst sentiment cannot be provided.  The analysis requires access to recent news sources and financial data platforms.


**7. Overall Summary:**

Intuitive Surgical demonstrates a history of strong performance significantly outpacing the S&P 500.  While recent price action shows a minor short-term downtrend, the longer-term trend appears positive.  The company shows consistent revenue and strong profit margins.  The high expected return and historical performance are noteworthy, but potential investors should exercise caution, considering the high beta and the fact that past performance doesn't guarantee future returns.  The analysis requires further investigation into current market sentiment, recent news events (including clarification on the duplicate earnings entry), and analyst opinions to gain a complete picture.  Furthermore, the expected return should be treated as a projection and not a guaranteed outcome.  A thorough review of financial statements and risk assessment is essential before making investment decisions.


**8. Disclaimer:** This analysis is based solely on the data provided. It is not financial advice.  Conduct thorough research and consult with a financial advisor before making any investment decisions.
